Research Purposes Only

Selank 10mg (Selank peptide) lyophilised research peptide vial — third-party lab-tested, for research use only

CNS Research Peptides

Selank

10mg

C₃₃H₅₇N₁₁O₉

Key Research Findings

  • Characterisation of the tuftsin-derived heptapeptide sequence.
  • Published rodent BDNF transcription assay data.
  • In-vitro IL-6 cytokine modulation studies.

Overview

Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin. Supplied as a lyophilised powder for in-vitro research use only.

Mechanism of Action

Reported in published in-vitro and animal-model studies to interact with the GABAergic system and to modulate BDNF transcription in cell-line assays. Not intended for human or veterinary use.

Research Effects

GABAergic Modulation Studies

Extensive Research

Reported in animal-model studies as a modulator of GABA receptor pathway activity.

BDNF Transcription Studies

Moderate Research

Published cell-culture assays report effects on BDNF gene transcription.

Cytokine-Expression Studies

Moderate Research

In-vitro studies report modulation of IL-6 and related cytokines in macrophage assays.

Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.

Quick Facts

Molecular FormulaC₃₃H₅₇N₁₁O₉
Molecular Weight751.88 g/mol
CAS Number129954-34-3
SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin analogue)
Half-Life~2–3 min (animal pharmacokinetic data)
SolubilityWater (1 mg/mL)
Storage−20 °C
More in CNS Research Peptides

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Featured in Bundles

Selank is included in the following Zenterex research peptide bundles.

Related Peptides

Cart